therefore, microorganisms resistant to these latter classes of antimicrobial agents may be susceptible to fluoroquinolones. v levaquin birth control. 2 µg/ml levaquin for dental infection. levofloxacin also penetrates into lung tissues. these recommendations apply to patients with normal renal function (i. do not stop taking levofloxacin without talking to your doctor. levofloxacin is contraindicated in persons with a history of hypersensitivity to levofloxacin, quinolone antimicrobial agents, or any other components of this product. other fluoroquinolones have been reported to increase blood levels of theophylline (theodur), warfarin (coumadin), and cyclosporine (sandimmune; neoral) levaquin leva pak. v. lung tissue concentrations were generally 2- to 5-fold higher than plasma concentrations and ranged from approximately 2. this risk is increased in patients over 65 years old, and is further increased with concomitant corticosteroid therapy std levaquin. excretion: the major route of elimination of levofloxacin in humans is as unchanged drug in urine. serious and occasionally fatal events, such as hypersensitivity and/or anaphylactic reactions, as well as some of unknown etiology have been reported in patients receiving therapy with quinolones, including levofloxacin. levofloxacin is in a class of antibiotics called fluoroquinolones. the quinolone should be discontinued in patients experiencing pain, inflammation, or rupture of a tendon 250mg levaquin. levofloxacin tablets can be administered without regard to food levaquin used for to treat. levofloxacin is not recommended for use in lactating women since levofloxacin causes joint and bone deformities in juvenile animals of several species. follow the directions on your prescription label carefully, and ask your doctor or pharmacist to explain any part you do not understand. levofloxacin also is frequently used to treat urinary infections, including those resistant to other antibiotics, as well as prostatitis. continue to take levofloxacin even if you feel well. levofloxacin binding to serum proteins is independent of the drug concentration. levaquin treat antibiotic can make your skin more sensitive to sunlight and sunburn may result. culture and susceptibility testing performed periodically during therapy will provide information about the continued susceptibility of the pathogens to the antimicrobial agent and also the possible emergence of bacterial resistance. taking these other medicines too close to your dose of levaquin treat antibiotic can make the antibiotic much less effective. levaquin treat antibiotic injection is indicated when intravenous administration offers a route of administration advantageous to the patient (e levaquin reaction. dosing regimens. treatment for some infections may take 6 weeks or longer. i. the peak and trough plasma concentrations attained following multiple once daily i. v. please see dosage and administration for specific recommendations. to reduce the development of drug-resistant bacteria and maintain the effectiveness of levaquin treat antibiotic® (levofloxacin) and other antibacterial drugs, levaquin treat antibiotic should be used only to treat or prevent infections that are proven or strongly suspected to be caused by susceptible bacteria. distribution: the mean volume of distribution of levofloxacin generally ranges from 89 to 112 l after single and multiple 500 mg doses, indicating widespread distribution into body tissues. for patients with altered renal function see the patients with impaired renal function subsection 500mg levaquin levofloxacin tablet. factors influencing the pharmacokinetics: special populations: geriatrics: there are no significant differences in levofloxacin pharmacokinetics between young and elderly subjects when the subjects' differences in creatinine clearance are taken into consideration.